Keith M. Rosenbloom
Known title: DirectorCIK: 0001190934
Keith M. Rosenbloom's purchase track record
How the stock did after each of Keith M. Rosenbloom's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 4 since May 16, 2023
Stock higher 6 months later
0%
3 months: 50%
Median 6-month return
-17.1%
3 months: -1.8%
Beat the S&P 500
0%
median -29.8% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/28/2024 | AVD | $1.08M | +6.3% | -7.9% | +6.5% |
| 5/15/2024 | AVD | $355K | -38.8% | -26.2% | +12.8% |
| 11/21/2023 | AVD | $52K | +17.8% | -3.5% | +17.3% |
| 5/16/2023 | AVD | $1.94M | -9.9% | -44.7% | +9.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| AVD | ▼ Sell | Open Market | 556,580 | $1.2M | 8/18/2026 | View on chart |
| AVD | ▲ Buy | Grant | 31,872 | $0 | 6/4/2026 | View on chart |
| AVD | ▼ Sell | Other | 217,503 | $0 | 11/26/2025 | View on chart |
| AVD | ▲ Buy | Grant | 17,621 | $0 | 8/7/2025 | View on chart |
| AVD | ▼ Sell | Other | 411,398 | — | 10/17/2024 | View on chart |
| AVD | ▲ Buy | Open Market | 7,000 | $43K | 9/4/2024 | View on chart |
| AVD | ▲ Buy | Open Market | 25,000 | $149K | 9/3/2024 | View on chart |
| AVD | ▲ Buy | Open Market | 104,492 | $600K | 8/30/2024 | View on chart |
| AVD | ▲ Buy | Open Market | 16,480 | $95K | 8/29/2024 | View on chart |
| AVD | ▲ Buy | Open Market | 33,555 | $190K | 8/28/2024 | View on chart |
| AVD | ▲ Buy | Grant | 9,174 | $0 | 6/6/2024 | View on chart |
| AVD | ▲ Buy | Open Market | 40,000 | $355K | 5/15/2024 | View on chart |
| AVD | ▲ Buy | Open Market | 5,700 | $52K | 11/21/2023 | View on chart |
| AVD | ▼ Sell | Other | 133,005 | — | 7/21/2023 | View on chart |
| AVD | ▲ Buy | Grant | 4,398 | $80K | 6/7/2023 | View on chart |
| AVD | ▲ Buy | Open Market | 7,000 | $121K | 5/22/2023 | View on chart |
| AVD | ▲ Buy | Open Market | 56,751 | $1.0M | 5/19/2023 | View on chart |
| AVD | ▲ Buy | Open Market | 6,498 | $110K | 5/18/2023 | View on chart |
| AVD | ▲ Buy | Open Market | 205 | $3K | 5/17/2023 | View on chart |
| AVD | ▲ Buy | Open Market | 41,359 | $693K | 5/16/2023 | View on chart |
| AVD | ▼ Sell | Other | 180,000 | $0 | 12/31/2022 | View on chart |
| AVD | ▼ Sell | Other | 10,000 | $175K | 11/18/2022 | View on chart |
| AVD | ▼ Sell | Other | 10,000 | $150K | 8/19/2022 | View on chart |
| AVD | ▲ Buy | Grant | 3,218 | $0 | 6/6/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
AVD to Acquire U.S. Crop-Protection Brands from Syngenta
American Vanguard has announced it will acquire the U.S. rights to four crop‑protection brands—Caparol, Evik, Prime+, and Agri‑Flex—from Syngenta. The deal is expected to generate more than $7 million in annual net sales for AVD. By adding these brands, the company expands its product portfolio and could strengthen its revenue base. The terms of the transaction were not disclosed.
AVD to Acquire U.S. Crop-Protection Brands from Syngenta. American Vanguard has announced it will acquire the U.S. rights to four crop‑protection brands—Caparol, Evik, Prime+, and Agri‑Flex—from Syngenta. The deal is expected to generate more than $7 million in annual net sales for AVD. By adding these brands, the company expands its product portfolio and could strengthen its revenue base. The terms of the transaction were not disclosed.